These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31103551)

  • 41. Acute effects of nimodipine on cerebral vasculature and brain metabolism in high grade subarachnoid hemorrhage patients.
    Choi HA; Ko SB; Chen H; Gilmore E; Carpenter AM; Lee D; Claassen J; Mayer SA; Schmidt JM; Lee K; Connelly ES; Paik M; Badjatia N
    Neurocrit Care; 2012 Jun; 16(3):363-7. PubMed ID: 22262041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone.
    Schmidt U; Bittner E; Pivi S; Marota JJ
    Anesth Analg; 2010 Mar; 110(3):895-902. PubMed ID: 20185665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage?
    Goel R; Aggarwal A; Salunke P; Kumar A; Chhabra R
    Br J Neurosurg; 2016 Aug; 30(4):407-10. PubMed ID: 26999260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety of Modified Nimodipine Dosing in Aneurysmal Subarachnoid Hemorrhage.
    Mahmoud L; Zullo AR; Blake C; Dai X; Thompson BB; Wendell LC; Furie KL; Reznik ME; Mahta A
    World Neurosurg; 2022 Feb; 158():e501-e508. PubMed ID: 34775086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
    von der Brelie C; Doukas A; Stopfer A; Larsen N; Mehdorn M; Synowitz M; Jansen O
    World Neurosurg; 2017 Apr; 100():504-513. PubMed ID: 28131927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nimodipine: test your drug IQ.
    Devlin MM
    Nursing; 2008 Jul; 38(7):56cc1-2. PubMed ID: 18580671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice.
    Velly LJ; Bilotta F; Fàbregas N; Soehle M; Bruder NJ; Nathanson MH;
    Eur J Anaesthesiol; 2015 Mar; 32(3):168-76. PubMed ID: 25303971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment following aneurysmal subarachnoid hemorrhage].
    Nemec K; Greif R
    Pharm Unserer Zeit; 2005; 34(5):412-6. PubMed ID: 16180364
    [No Abstract]   [Full Text] [Related]  

  • 53. Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage.
    Tettenborn D; Dycka J; Volberg E; Düdden P
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():84-6. PubMed ID: 4010871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic effects of intravenous nimodipine following aneurysmal subarachnoid haemorrhage: implications for monitoring.
    Radhakrishnan D; Menon DK
    Anaesthesia; 1997 May; 52(5):489-91. PubMed ID: 9165970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke.
    Ahmed N; Näsman P; Wahlgren NG
    Stroke; 2000 Jun; 31(6):1250-5. PubMed ID: 10835440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    van den Bergh WM; Mees SM; Rinkel GJ
    Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage.
    Daou BJ; Koduri S; Thompson BG; Chaudhary N; Pandey AS
    CNS Neurosci Ther; 2019 Oct; 25(10):1096-1112. PubMed ID: 31583833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel rescue therapy for cerebral vasospasm: Cisternal Nimodipine application via stereotactic catheter ventriculocisternostomy.
    Roelz R; Scheiwe C; Coenen VA; Reinacher PC
    J Clin Neurosci; 2019 May; 63():244-248. PubMed ID: 30737093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
    Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
    J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm.
    Gioia AE; White RP; Bakhtian B; Robertson JT
    J Neurosurg; 1985 May; 62(5):721-8. PubMed ID: 3838768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.